Tag: Hepatocellular carcinoma
-
DAA Therapy: Persistent HCC Risk in HIV-HCV Coinfection Explained
Understanding the Context: HIV, HCV, and HCC Hepatitis C virus (HCV) infection and human immunodeficiency virus (HIV) coinfection pose unique health challenges. In the past decade, direct-acting antivirals (DAAs) transformed HCV treatment, offering high cure rates and improved liver outcomes. However, even after what appears to be a sustained virologic response or cure, researchers have…
-
DAA Therapy and HCC Risk in HIV-HCV Coinfection: Decline Over Time
Overview: HIV, HCV, and the risk of hepatocellular carcinoma Hepatocellular carcinoma (HCC) remains a major concern for people living with HIV who have a history of hepatitis C virus (HCV) infection. Even after successful HCV cure with direct-acting antivirals (DAAs), researchers have observed that the risk of developing HCC does not disappear entirely. This evolving…
-
DAA Therapy Linked to Falling HCC Risk in HIV-HCV Coinfection
Hepatitis C, HIV, and the evolving role of DAAs Direct-acting antivirals (DAAs) have transformed hepatitis C virus (HCV) treatment, offering cure rates that were once unimaginable. For people living with both HIV and HCV, the landscape has been more complex. While DAAs effectively clear the hepatitis C infection, experts have long asked how this virologic…
-
Exact Sciences Unveils Breakthrough Blood Test for Early Liver Cancer Detection
Groundbreaking Validation of a Blood-Based Liver Cancer Screening Tool Exact Sciences Corp. has announced pivotal clinical validation results from the ALTUS study, a prospective, head-to-head evaluation designed to assess a blood-based surveillance test for liver cancer. Conducted in a real-world, high-risk population, the ALTUS study (NCT: 05064553) represents a major step toward accessible, non-invasive screening…
-
Free, Nurse-Led Support Line Opens for Primary Liver Cancer During Liver Cancer Awareness Month
A New Lifeline for Primary Liver Cancer Patients In a significant move to bolster support for those affected by primary liver cancer, the Liver Foundation has launched a free, nurse-led support line during Liver Cancer Awareness Month. The service is designed to provide expert guidance, compassionate listening, and practical information to patients and their loved…